GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $147,000 | -41.4% | 3,450 | -36.7% | 0.14% | -42.1% |
| Q3 2014 | $251,000 | -53.2% | 5,450 | -45.6% | 0.24% | -47.4% |
| Q2 2014 | $536,000 | 0.0% | 10,015 | 0.0% | 0.46% | -1.7% |
| Q1 2014 | $536,000 | -3.8% | 10,015 | -4.0% | 0.46% | -3.1% |
| Q4 2013 | $557,000 | +31.7% | 10,435 | +23.7% | 0.48% | +22.5% |
| Q3 2013 | $423,000 | -35.9% | 8,435 | -36.1% | 0.39% | -36.2% |
| Q2 2013 | $660,000 | – | 13,205 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |